Mesoblast to Host First Quarter Financial Results Conference Call and Webcast on 16 December 2015

MELBOURNE, Australia and NEW YORK, Dec. 15, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced it will report financial results for the quarter ended 30 September 2015 after the close of the Nasdaq market on Wednesday 16 December. Mesoblast management will host a conference call to review results and provide a corporate update beginning at 5:00 pm Eastern Time on Wednesday, 16 December / 09:00 am Australian Eastern Daylight Time on Thursday, 17 December.

To access the call, dial 855-298-3404 (toll-free US), 1800-801-825 (toll-free Australia) or +1 631-514-2526 (outside of the US). The passcode is 6205376. The conference call will be accompanied by a slide presentation. Please log in approximately 10 minutes prior to the scheduled start time. The live webcast will be available at and The archived webcast will be available in the Events and Presentations section of the Investor page on the Company's website.

About Mesoblast
Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) is a global leader in cell-based medicines. The Company has leveraged its proprietary technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a broad portfolio of late-stage product candidates. Mesoblast’s allogeneic, ‘off-the-shelf’ cell product candidates target advanced stages of diseases where there are highly unmet medical needs, including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncology/hematology conditions.

For further information, please contact: Michael Schuster Head, Investor Relations Mesoblast Limited T: 212-880-2060 E: Julie Meldrum Global Head, Corporate Communications Mesoblast Limited T: +61 3 9639 6036 E:

Source:Mesoblast Limited